Over ait malign dysgerminoma paraaortic lenf dugumu metastasi [Overe ai·t mali·gn di·sgermi·nomda paraaorti·k lenf dügümü metastazi]
| dc.contributor.author | Terek M.C. | |
| dc.contributor.author | Hurşitoglu B.S. | |
| dc.contributor.author | Sözbilen M. | |
| dc.contributor.author | Dikmen Y. | |
| dc.contributor.author | Zekioglu O. | |
| dc.date.accessioned | 2019-10-26T21:56:37Z | |
| dc.date.available | 2019-10-26T21:56:37Z | |
| dc.date.issued | 2011 | |
| dc.department | Ege Üniversitesi | en_US |
| dc.description.abstract | Dysgerminomas comprise approximately %2-5 of all ovarian malignancies and mostly affect young adolescent women. Comprehensive initial surgery including systematic paraaortic lymphadenectomy and adjuvant chemotherapy at tertiary gynecologic oncology centers (1). The treatment for advanced stages (FIGO II-IV) consistS of adjuvant chemotherapy including bleomycin,etoposide and cicplatin (BEP) in addition to primary comprehensive surgery (4). | en_US |
| dc.identifier.endpage | 63 | en_US |
| dc.identifier.issn | 1301-8841 | |
| dc.identifier.issn | 1301-8841 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.scopusquality | N/A | en_US |
| dc.identifier.startpage | 61 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11454/19032 | |
| dc.identifier.volume | 14 | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Turk Jinekolojik Onkoloji Dergisi | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Dysgerminoma | en_US |
| dc.subject | Paraaortic lymp node metastasis | en_US |
| dc.title | Over ait malign dysgerminoma paraaortic lenf dugumu metastasi [Overe ai·t mali·gn di·sgermi·nomda paraaorti·k lenf dügümü metastazi] | en_US |
| dc.type | Article | en_US |
